A cross-sectional survey of 618 outpatients at a Thai hospital near the Cambodian border found that while most people knew cannabis had been legalized, over 60% could not correctly identify its approved medical uses or known side effects. The gap was most pronounced among older adults, those with lower education levels, and Village Health Volunteers tasked with community health education.

Thailand’s 2022 cannabis decriminalization made it the first country in Asia to liberalize cannabis policy at this scale, but the speed of that regulatory shift raised immediate questions about whether public understanding could keep pace. In border communities where cannabis already moves through both official and unofficial channels, the stakes are higher: uninformed use risks adverse health outcomes, missed therapeutic opportunities, and strained frontline health systems. This study provides rare primary data from exactly such a community, revealing how wide the gap between legal awareness and health literacy truly is.

Thailand’s 2022 cannabis decriminalization generated widespread public awareness but also created uncertainty about what cannabis can and cannot treat, particularly in underserved rural and border communities. This cross-sectional survey sought to assess the depth of medical cannabis knowledge among outpatients at a 30-bed community hospital in northeastern Thailand’s Thai-Cambodian border region. Data were collected between March and August 2024 through face-to-face interviews using a structured questionnaire administered in a private setting. The sampling approach selected every fourth patient arriving at the hospital’s weighing station, yielding 618 participants ranging from 18 to 86 years old. The sample was 69.4% female, reflecting the composition of the facility’s outpatient population.

Only 14.24% of respondents reported any prior cannabis use, a rate lower than national survey estimates. More strikingly, over 60% of participants answered “don’t know” when asked about cannabis therapeutic benefits or adverse effects, despite the majority being aware of legalization. Knowledge differences were observed across age and education groups, though no multivariate regression was reported in the available text. Notably, Village Health Volunteers, who serve as primary health communicators in Thai rural communities, showed relatively low cannabis knowledge. The study’s principal limitations include its single-site design, heavy female skew, and cross-sectional structure, which precludes causal claims. The authors call for targeted public education and culturally adapted communication strategies, while acknowledging that broader validation is needed.

Legal but Not Understood: Cannabis Knowledge Gaps in Thailand’s Border Communities

Thailand made history in 2022 by becoming the first Asian country to decriminalize cannabis, but a new survey from a hospital on the Thai-Cambodian border suggests the announcement reached far more people than the education did. This study surveyed 618 outpatients at a small community hospital and found something that will be familiar to anyone who has watched a new medication receive regulatory approval: knowing that something is available is not at all the same as knowing what it does. Over 60% of the people surveyed could not correctly identify what cannabis treats medically or what its known side effects are. They knew the law had changed. They did not know why it mattered clinically. That distinction is not trivial. It is the difference between a patient making an informed decision and a patient making a guess.

The study’s most striking contribution is its finding about Village Health Volunteers. In Thailand’s rural health system, these volunteers function as the primary bridge between formal medical knowledge and community behavior. They are the person whose job it is to read you the map. This study suggests that, at least when it comes to cannabis, they do not know the route either. If the people tasked with health communication cannot accurately answer basic questions about cannabis safety and indications, the entire downstream information chain is compromised. That is a structurally addressable problem, and it is more actionable than many of the study’s other findings. To its credit, the research captures a genuine moment in time: a border community navigating a regulatory transition with cannabis flowing in both directions, through clinics and through unofficial channels, while the people most exposed to risk have the least reliable information.

I want to be honest about the study’s limits. This is a single 30-bed hospital’s outpatient department. The sample is nearly 70% female. The title references “Northeastern Thai citizens,” but the evidence supports claims about one clinic’s patients, not a region. No multivariate analysis is presented, so we cannot tell whether age and education effects are truly independent or simply correlated with each other. What I would say to a patient is direct: the fact that cannabis is legal does not mean it is automatically safe for your condition, and your best first step is a conversation with a provider who knows your full history. What I would say to a policymaker is equally direct: you changed the law faster than you changed the knowledge base, and this study, modest as it is, shows that the information deficit is real. In cannabis policy transitions, the gap between legal status and health literacy is not self-correcting. It requires deliberate, targeted, and culturally adapted public education that reaches frontline health communicators before it reaches mass media.

This study sits at the very beginning of the research arc for post-legalization cannabis health literacy in Southeast Asia. It is descriptive and hypothesis-generating rather than hypothesis-testing. For clinicians working in cannabis medicine, the findings serve as a useful reminder that regulatory access does not translate into patient comprehension. The documented knowledge gaps among Village Health Volunteers are particularly concerning because these individuals represent the primary informal health education infrastructure in Thai rural settings, and their deficits likely multiply through entire communities.

From a pharmacological and safety standpoint, the over-60% “don’t know” rate on adverse effects is clinically worrying. Patients who cannot identify common cannabis side effects are poorly positioned to report them, recognize drug interactions, or adjust their use behavior. In a border community where cannabis products may arrive through unregulated channels, this knowledge gap amplifies risks related to product quality, dosing inconsistency, and contamination. Clinicians should actively screen for cannabis use in similar populations, provide structured education about both therapeutic possibilities and known risks, and not assume that patients who report awareness of legalization have any substantive understanding of what medical cannabis involves in practice.

This is an original cross-sectional quantitative survey, which sits in the lower-middle tier of the evidence hierarchy. It can describe associations between demographic characteristics and knowledge levels at a single point in time, but it cannot establish causal relationships, temporal sequences, or population-level prevalence. The most important inference constraint is that findings from one 30-bed border hospital’s outpatient department cannot be generalized to northeastern Thailand or Thailand as a whole.

The finding that legal awareness outstrips substantive health knowledge is consistent with patterns observed in other post-legalization contexts. Health Canada’s 2023 data on cannabis use patterns among Canadian youth following liberalization documented similar gaps between regulatory awareness and health-behavior outcomes. Garcia et al. (2024), studying U.S.-Mexico border communities, found comparable dynamics in which cross-border cannabis flows complicated public health messaging. What this Thai study adds is a Southeast Asian data point in a region where cannabis legalization is still a novel phenomenon, and where the cultural and infrastructural context differs substantially from North American settings.

Notably, the Center for Addiction Studies (2019) had previously identified northeastern Thailand as having the country’s highest cannabis usage rates, which makes the relatively low 14.24% ever-use rate in this sample worth interrogating. The difference likely reflects the sample’s demographic composition rather than a true regional trend, reinforcing the importance of not overgeneralizing these findings.

The most consequential analytic choice is the absence of multivariate regression. The study reports knowledge differences by age and education, but without adjusting for covariates, it is impossible to determine whether these are independent effects or artifacts of their mutual correlation. An older patient with less formal education may appear to have lower knowledge due to age, education, or both, but also due to confounders such as health literacy, media access, or proximity to cannabis-using social networks. A logistic regression model adjusting for age, education, gender, occupation, and prior cannabis use would have substantially clarified which demographic factors independently predicted knowledge deficits, and whether the Village Health Volunteer finding persists after controlling for education level.

The most likely overinterpretation is treating the 14.24% cannabis use prevalence as representative of northeastern Thailand. This figure comes from a single hospital’s outpatient population that is nearly 70% female and skews older, a demographic profile that would predictably produce lower use rates than the general population. Similarly, the over-60% “don’t know” rate should not be read as evidence of opposition to or fear of cannabis. It reflects uncertainty and lack of exposure to information, not necessarily negative attitudes. Finally, the study’s title references “Northeastern Thai citizens,” but the sampling frame supports conclusions only about outpatients at this particular facility during a specific five-month window.

This study contributes a timely, if narrow, snapshot of cannabis health literacy in a Thai border community during a regulatory transition. It demonstrates that awareness of legalization does not equal understanding of medical use or safety. It does not establish causal relationships, population-level prevalence, or the effectiveness of any intervention. For practice, the most actionable finding is that frontline health communicators in rural Thailand may need targeted cannabis education before they can effectively serve the communities that rely on them.

What did this study actually measure?

Researchers interviewed 618 patients at a small Thai hospital near the Cambodian border to assess how much they knew about the approved medical uses and side effects of cannabis, and whether demographic factors like age and education were associated with higher or lower knowledge levels.

Does this study prove that Thai people don’t understand medical cannabis?

No. It shows that outpatients at one specific hospital had significant knowledge gaps, but the findings cannot be extended to the Thai population as a whole. The sample was predominantly female and older, which may not reflect broader national patterns.

Why does the finding about Village Health Volunteers matter?

Village Health Volunteers are Thailand’s primary mechanism for delivering health education in rural communities. If they lack accurate knowledge about cannabis, the communities they serve are unlikely to receive reliable information through official channels. This suggests that targeted training for these volunteers could be a high-impact, relatively low-cost intervention.

Should I rely on this study to make decisions about my own cannabis use?

This study does not provide clinical guidance about whether cannabis is appropriate for any specific condition. It highlights the importance of speaking with a licensed healthcare provider who can evaluate your individual health history, discuss potential benefits and risks, and help you make an informed decision rather than relying on general awareness alone.

Have thoughts on this? Share it: